ADIPOQ and polycystic ovary syndrome: (2014) involving normal-weight women (BMI<23) aged 16–35 years with PCOS showed that adiponectin may be an independent diagnostic marker for PCOS in young normal-weight patients with less severe clinical symptoms of the syndrome or in a group of women with a positive family history of PCOS, as its levels are independently associated with PCOS (37).